HEADER HYDROLASE 11-APR-14 4CYF TITLE THE STRUCTURE OF VANIN-1: DEFINING THE LINK BETWEEN METABOLIC DISEASE, TITLE 2 OXIDATIVE STRESS AND INFLAMMATION CAVEAT 4CYF NAG C 2 HAS WRONG CHIRALITY AT ATOM C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PANTETHEINASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: MATURE PROTEIN, RESIDUES 22-513; COMPND 5 SYNONYM: PANTETHEINE HYDROLASE, TIFF66, VASCULAR NON-INFLAMMATORY COMPND 6 MOLECULE 1, VANIN-1, HUMAN VANIN-1; COMPND 7 EC: 3.5.1.92; COMPND 8 ENGINEERED: YES; COMPND 9 OTHER_DETAILS: FLAG TAG AT N-TERMINUS SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 6 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: HEK 293S; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PAPEX-3P; SOURCE 10 OTHER_DETAILS: SYNTHESIZED DNA KEYWDS HYDROLASE, INFLAMMATION, COLITIS, COA BIOSYNTHESIS OXIDATIVE STRESS EXPDTA X-RAY DIFFRACTION AUTHOR Y.L.BOERSMA,J.NEWMAN,T.E.ADAMS,L.SPARROW,N.COWIESON,D.LUCENT, AUTHOR 2 G.KRIPPNER,K.BOZAOGLU,T.S.PEAT REVDAT 5 29-JUL-20 4CYF 1 CAVEAT COMPND REMARK HETNAM REVDAT 5 2 1 LINK SITE ATOM REVDAT 4 08-MAY-19 4CYF 1 REMARK REVDAT 3 14-JUN-17 4CYF 1 ATOM REVDAT 2 25-FEB-15 4CYF 1 JRNL REVDAT 1 10-DEC-14 4CYF 0 JRNL AUTH Y.L.BOERSMA,J.NEWMAN,T.E.ADAMS,N.COWIESON,G.KRIPPNER, JRNL AUTH 2 K.BOZAOGLU,T.S.PEAT JRNL TITL THE STRUCTURE OF VANIN-1: A KEY ENZYME LINKING METABOLIC JRNL TITL 2 DISEASE AND INFLAMMATION JRNL REF ACTA CRYSTALLOGR.,SECT.D V. 70 3320 2014 JRNL REFN ISSN 0907-4449 JRNL PMID 25478849 JRNL DOI 10.1107/S1399004714022767 REMARK 2 REMARK 2 RESOLUTION. 2.25 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0069 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.25 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 105.51 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 73353 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.197 REMARK 3 R VALUE (WORKING SET) : 0.195 REMARK 3 FREE R VALUE : 0.222 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3872 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.25 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.31 REMARK 3 REFLECTION IN BIN (WORKING SET) : 5292 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.34 REMARK 3 BIN R VALUE (WORKING SET) : 0.2960 REMARK 3 BIN FREE R VALUE SET COUNT : 262 REMARK 3 BIN FREE R VALUE : 0.3100 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7264 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 112 REMARK 3 SOLVENT ATOMS : 240 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 40.41 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.88000 REMARK 3 B22 (A**2) : 0.88000 REMARK 3 B33 (A**2) : -1.75000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.190 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.164 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.125 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.275 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.953 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.936 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 7665 ; 0.007 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 6966 ; 0.003 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 10457 ; 1.252 ; 1.961 REMARK 3 BOND ANGLES OTHERS (DEGREES): 16031 ; 0.832 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 937 ; 6.679 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 358 ;36.705 ;24.581 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1184 ;13.557 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 30 ;19.277 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1163 ; 0.073 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 8757 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 1803 ; 0.003 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3733 ; 2.611 ; 5.128 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 3732 ; 2.611 ; 5.127 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4675 ; 4.082 ; 8.645 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 3932 ; 3.248 ; 5.685 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. U VALUES REFINED INDIVIDUALLY. WE FIND GLYCOSYLATION REMARK 3 AT ASN RESIDUES 38, 130, 315 AND 353 IN THIS CRYSTAL FORM. WE REMARK 3 ALSO FIND GLYCOSYLATION AT POSITION 200 IN A DIFFERENT CRYSTAL REMARK 3 FORM AND THIS IS CONFIRMED BY MASS SPEC ANALYSIS. REMARK 4 REMARK 4 4CYF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 11-APR-14. REMARK 100 THE DEPOSITION ID IS D_1290060313. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-NOV-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.95370 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADXV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 77299 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.250 REMARK 200 RESOLUTION RANGE LOW (A) : 48.300 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 14.80 REMARK 200 R MERGE (I) : 0.14000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.25 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.37 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.3 REMARK 200 DATA REDUNDANCY IN SHELL : 14.50 REMARK 200 R MERGE FOR SHELL (I) : 1.18000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SIRAS REMARK 200 SOFTWARE USED: AUTO-RICKSHAW REMARK 200 STARTING MODEL: NONE REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 68.40 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.89 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN WAS AT 12 MG/ML IN 50 MM BIS REMARK 280 -TRIS PH 6.5 WITH 50 MM NACL. THE RESERVOIR WAS 21% PEG 1500 REMARK 280 WITH 10% (V/V) MALATE-MES-TRIS BUFFER AT PH 6.3. 200 NL PLUS 200 REMARK 280 NL DROPS IN SITTING DROP PLATES., VAPOR DIFFUSION, SITTING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 110.94350 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 59.97050 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 59.97050 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 166.41525 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 59.97050 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 59.97050 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 55.47175 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 59.97050 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 59.97050 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 166.41525 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 59.97050 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 59.97050 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 55.47175 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 110.94350 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 8 REMARK 465 SER A 9 REMARK 465 ILE A 10 REMARK 465 SER A 11 REMARK 465 ALA A 12 REMARK 465 ARG A 13 REMARK 465 ASP A 14 REMARK 465 TYR A 15 REMARK 465 LYS A 16 REMARK 465 ASP A 17 REMARK 465 ASP A 18 REMARK 465 ASP A 19 REMARK 465 ASP A 20 REMARK 465 LYS A 21 REMARK 465 TRP A 484 REMARK 465 ALA A 485 REMARK 465 SER A 486 REMARK 465 ASN A 487 REMARK 465 ALA A 488 REMARK 465 SER A 489 REMARK 465 SER A 490 REMARK 465 GLY A 491 REMARK 465 LEU A 492 REMARK 465 THR A 493 REMARK 465 ALA A 494 REMARK 465 GLN A 495 REMARK 465 ALA A 496 REMARK 465 ARG A 497 REMARK 465 ILE A 498 REMARK 465 ILE A 499 REMARK 465 MET A 500 REMARK 465 LEU A 501 REMARK 465 ILE A 502 REMARK 465 VAL A 503 REMARK 465 ILE A 504 REMARK 465 ALA A 505 REMARK 465 PRO A 506 REMARK 465 ILE A 507 REMARK 465 VAL A 508 REMARK 465 CYS A 509 REMARK 465 SER A 510 REMARK 465 LEU A 511 REMARK 465 SER A 512 REMARK 465 TRP A 513 REMARK 465 ALA B 8 REMARK 465 SER B 9 REMARK 465 ILE B 10 REMARK 465 SER B 11 REMARK 465 ALA B 12 REMARK 465 ARG B 13 REMARK 465 ASP B 14 REMARK 465 TYR B 15 REMARK 465 LYS B 16 REMARK 465 ASP B 17 REMARK 465 ASP B 18 REMARK 465 ASP B 19 REMARK 465 ASP B 20 REMARK 465 LYS B 21 REMARK 465 TRP B 484 REMARK 465 ALA B 485 REMARK 465 SER B 486 REMARK 465 ASN B 487 REMARK 465 ALA B 488 REMARK 465 SER B 489 REMARK 465 SER B 490 REMARK 465 GLY B 491 REMARK 465 LEU B 492 REMARK 465 THR B 493 REMARK 465 ALA B 494 REMARK 465 GLN B 495 REMARK 465 ALA B 496 REMARK 465 ARG B 497 REMARK 465 ILE B 498 REMARK 465 ILE B 499 REMARK 465 MET B 500 REMARK 465 LEU B 501 REMARK 465 ILE B 502 REMARK 465 VAL B 503 REMARK 465 ILE B 504 REMARK 465 ALA B 505 REMARK 465 PRO B 506 REMARK 465 ILE B 507 REMARK 465 VAL B 508 REMARK 465 CYS B 509 REMARK 465 SER B 510 REMARK 465 LEU B 511 REMARK 465 SER B 512 REMARK 465 TRP B 513 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD1 ASP B 218 O HOH B 701 2.12 REMARK 500 ND2 ASN A 130 O5 NAG A 601 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 105 78.49 60.56 REMARK 500 ASN A 113 -1.41 77.06 REMARK 500 CSO A 211 -111.45 39.15 REMARK 500 TYR A 269 83.39 -153.55 REMARK 500 THR A 275 137.16 -176.58 REMARK 500 SER A 311 -164.62 -67.59 REMARK 500 LYS A 359 -117.29 43.52 REMARK 500 GLU A 371 147.26 -171.00 REMARK 500 THR A 405 -169.37 -118.37 REMARK 500 ASN B 105 77.31 60.16 REMARK 500 GLU B 185 53.29 -90.10 REMARK 500 CSO B 211 -113.50 38.92 REMARK 500 TYR B 269 81.47 -154.23 REMARK 500 THR B 275 138.21 -175.49 REMARK 500 SER B 284 162.05 178.26 REMARK 500 SER B 284 161.91 178.26 REMARK 500 LYS B 359 -117.61 43.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4CYG RELATED DB: PDB REMARK 900 THE STRUCTURE OF VANIN-1: DEFINING THE LINK BETWEEN METABOLIC REMARK 900 DISEASE, OXIDATIVE STRESS AND INFLAMMATION REMARK 900 RELATED ID: 4CYU RELATED DB: PDB REMARK 900 STAPHYLOCOCCUS AUREUS 7,8-DIHYDRO-6-HYDROXYMETHYLPTERIN- REMARK 900 PYROPHOSPHOKINASE IN COMPLEX WITH AMPCPP REMARK 999 REMARK 999 SEQUENCE REMARK 999 FLAG TAG AT N-TERMINUS. PRO-PEPTIDE AT C-TERMINUS HAS BEEN REMARK 999 REMOVED IN CONSTRUCT TO GIVE THE MATURE PROTEIN DBREF 4CYF A 22 513 UNP O95497 VNN1_HUMAN 22 513 DBREF 4CYF B 22 513 UNP O95497 VNN1_HUMAN 22 513 SEQADV 4CYF ALA A 8 UNP O95497 EXPRESSION TAG SEQADV 4CYF SER A 9 UNP O95497 EXPRESSION TAG SEQADV 4CYF ILE A 10 UNP O95497 EXPRESSION TAG SEQADV 4CYF SER A 11 UNP O95497 EXPRESSION TAG SEQADV 4CYF ALA A 12 UNP O95497 EXPRESSION TAG SEQADV 4CYF ARG A 13 UNP O95497 EXPRESSION TAG SEQADV 4CYF ASP A 14 UNP O95497 EXPRESSION TAG SEQADV 4CYF TYR A 15 UNP O95497 EXPRESSION TAG SEQADV 4CYF LYS A 16 UNP O95497 EXPRESSION TAG SEQADV 4CYF ASP A 17 UNP O95497 EXPRESSION TAG SEQADV 4CYF ASP A 18 UNP O95497 EXPRESSION TAG SEQADV 4CYF ASP A 19 UNP O95497 EXPRESSION TAG SEQADV 4CYF ASP A 20 UNP O95497 EXPRESSION TAG SEQADV 4CYF LYS A 21 UNP O95497 EXPRESSION TAG SEQADV 4CYF ILE A 26 UNP O95497 THR 26 VARIANT SEQADV 4CYF ALA B 8 UNP O95497 EXPRESSION TAG SEQADV 4CYF SER B 9 UNP O95497 EXPRESSION TAG SEQADV 4CYF ILE B 10 UNP O95497 EXPRESSION TAG SEQADV 4CYF SER B 11 UNP O95497 EXPRESSION TAG SEQADV 4CYF ALA B 12 UNP O95497 EXPRESSION TAG SEQADV 4CYF ARG B 13 UNP O95497 EXPRESSION TAG SEQADV 4CYF ASP B 14 UNP O95497 EXPRESSION TAG SEQADV 4CYF TYR B 15 UNP O95497 EXPRESSION TAG SEQADV 4CYF LYS B 16 UNP O95497 EXPRESSION TAG SEQADV 4CYF ASP B 17 UNP O95497 EXPRESSION TAG SEQADV 4CYF ASP B 18 UNP O95497 EXPRESSION TAG SEQADV 4CYF ASP B 19 UNP O95497 EXPRESSION TAG SEQADV 4CYF ASP B 20 UNP O95497 EXPRESSION TAG SEQADV 4CYF LYS B 21 UNP O95497 EXPRESSION TAG SEQADV 4CYF ILE B 26 UNP O95497 THR 26 VARIANT SEQRES 1 A 506 ALA SER ILE SER ALA ARG ASP TYR LYS ASP ASP ASP ASP SEQRES 2 A 506 LYS GLN ASP THR PHE ILE ALA ALA VAL TYR GLU HIS ALA SEQRES 3 A 506 ALA ILE LEU PRO ASN ALA THR LEU THR PRO VAL SER ARG SEQRES 4 A 506 GLU GLU ALA LEU ALA LEU MET ASN ARG ASN LEU ASP ILE SEQRES 5 A 506 LEU GLU GLY ALA ILE THR SER ALA ALA ASP GLN GLY ALA SEQRES 6 A 506 HIS ILE ILE VAL THR PRO GLU ASP ALA ILE TYR GLY TRP SEQRES 7 A 506 ASN PHE ASN ARG ASP SER LEU TYR PRO TYR LEU GLU ASP SEQRES 8 A 506 ILE PRO ASP PRO GLU VAL ASN TRP ILE PRO CYS ASN ASN SEQRES 9 A 506 ARG ASN ARG PHE GLY GLN THR PRO VAL GLN GLU ARG LEU SEQRES 10 A 506 SER CYS LEU ALA LYS ASN ASN SER ILE TYR VAL VAL ALA SEQRES 11 A 506 ASN ILE GLY ASP LYS LYS PRO CYS ASP THR SER ASP PRO SEQRES 12 A 506 GLN CYS PRO PRO ASP GLY ARG TYR GLN TYR ASN THR ASP SEQRES 13 A 506 VAL VAL PHE ASP SER GLN GLY LYS LEU VAL ALA ARG TYR SEQRES 14 A 506 HIS LYS GLN ASN LEU PHE MET GLY GLU ASN GLN PHE ASN SEQRES 15 A 506 VAL PRO LYS GLU PRO GLU ILE VAL THR PHE ASN THR THR SEQRES 16 A 506 PHE GLY SER PHE GLY ILE PHE THR CSO PHE ASP ILE LEU SEQRES 17 A 506 PHE HIS ASP PRO ALA VAL THR LEU VAL LYS ASP PHE HIS SEQRES 18 A 506 VAL ASP THR ILE VAL PHE PRO THR ALA TRP MET ASN VAL SEQRES 19 A 506 LEU PRO HIS LEU SER ALA VAL GLU PHE HIS SER ALA TRP SEQRES 20 A 506 ALA MET GLY MET ARG VAL ASN PHE LEU ALA SER ASN ILE SEQRES 21 A 506 HIS TYR PRO SER LYS LYS MET THR GLY SER GLY ILE TYR SEQRES 22 A 506 ALA PRO ASN SER SER ARG ALA PHE HIS TYR ASP MET LYS SEQRES 23 A 506 THR GLU GLU GLY LYS LEU LEU LEU SER GLN LEU ASP SER SEQRES 24 A 506 HIS PRO SER HIS SER ALA VAL VAL ASN TRP THR SER TYR SEQRES 25 A 506 ALA SER SER ILE GLU ALA LEU SER SER GLY ASN LYS GLU SEQRES 26 A 506 PHE LYS GLY THR VAL PHE PHE ASP GLU PHE THR PHE VAL SEQRES 27 A 506 LYS LEU THR GLY VAL ALA GLY ASN TYR THR VAL CYS GLN SEQRES 28 A 506 LYS ASP LEU CYS CYS HIS LEU SER TYR LYS MET SER GLU SEQRES 29 A 506 ASN ILE PRO ASN GLU VAL TYR ALA LEU GLY ALA PHE ASP SEQRES 30 A 506 GLY LEU HIS THR VAL GLU GLY ARG TYR TYR LEU GLN ILE SEQRES 31 A 506 CYS THR LEU LEU LYS CYS LYS THR THR ASN LEU ASN THR SEQRES 32 A 506 CYS GLY ASP SER ALA GLU THR ALA SER THR ARG PHE GLU SEQRES 33 A 506 MET PHE SER LEU SER GLY THR PHE GLY THR GLN TYR VAL SEQRES 34 A 506 PHE PRO GLU VAL LEU LEU SER GLU ASN GLN LEU ALA PRO SEQRES 35 A 506 GLY GLU PHE GLN VAL SER THR ASP GLY ARG LEU PHE SER SEQRES 36 A 506 LEU LYS PRO THR SER GLY PRO VAL LEU THR VAL THR LEU SEQRES 37 A 506 PHE GLY ARG LEU TYR GLU LYS ASP TRP ALA SER ASN ALA SEQRES 38 A 506 SER SER GLY LEU THR ALA GLN ALA ARG ILE ILE MET LEU SEQRES 39 A 506 ILE VAL ILE ALA PRO ILE VAL CYS SER LEU SER TRP SEQRES 1 B 506 ALA SER ILE SER ALA ARG ASP TYR LYS ASP ASP ASP ASP SEQRES 2 B 506 LYS GLN ASP THR PHE ILE ALA ALA VAL TYR GLU HIS ALA SEQRES 3 B 506 ALA ILE LEU PRO ASN ALA THR LEU THR PRO VAL SER ARG SEQRES 4 B 506 GLU GLU ALA LEU ALA LEU MET ASN ARG ASN LEU ASP ILE SEQRES 5 B 506 LEU GLU GLY ALA ILE THR SER ALA ALA ASP GLN GLY ALA SEQRES 6 B 506 HIS ILE ILE VAL THR PRO GLU ASP ALA ILE TYR GLY TRP SEQRES 7 B 506 ASN PHE ASN ARG ASP SER LEU TYR PRO TYR LEU GLU ASP SEQRES 8 B 506 ILE PRO ASP PRO GLU VAL ASN TRP ILE PRO CYS ASN ASN SEQRES 9 B 506 ARG ASN ARG PHE GLY GLN THR PRO VAL GLN GLU ARG LEU SEQRES 10 B 506 SER CYS LEU ALA LYS ASN ASN SER ILE TYR VAL VAL ALA SEQRES 11 B 506 ASN ILE GLY ASP LYS LYS PRO CYS ASP THR SER ASP PRO SEQRES 12 B 506 GLN CYS PRO PRO ASP GLY ARG TYR GLN TYR ASN THR ASP SEQRES 13 B 506 VAL VAL PHE ASP SER GLN GLY LYS LEU VAL ALA ARG TYR SEQRES 14 B 506 HIS LYS GLN ASN LEU PHE MET GLY GLU ASN GLN PHE ASN SEQRES 15 B 506 VAL PRO LYS GLU PRO GLU ILE VAL THR PHE ASN THR THR SEQRES 16 B 506 PHE GLY SER PHE GLY ILE PHE THR CSO PHE ASP ILE LEU SEQRES 17 B 506 PHE HIS ASP PRO ALA VAL THR LEU VAL LYS ASP PHE HIS SEQRES 18 B 506 VAL ASP THR ILE VAL PHE PRO THR ALA TRP MET ASN VAL SEQRES 19 B 506 LEU PRO HIS LEU SER ALA VAL GLU PHE HIS SER ALA TRP SEQRES 20 B 506 ALA MET GLY MET ARG VAL ASN PHE LEU ALA SER ASN ILE SEQRES 21 B 506 HIS TYR PRO SER LYS LYS MET THR GLY SER GLY ILE TYR SEQRES 22 B 506 ALA PRO ASN SER SER ARG ALA PHE HIS TYR ASP MET LYS SEQRES 23 B 506 THR GLU GLU GLY LYS LEU LEU LEU SER GLN LEU ASP SER SEQRES 24 B 506 HIS PRO SER HIS SER ALA VAL VAL ASN TRP THR SER TYR SEQRES 25 B 506 ALA SER SER ILE GLU ALA LEU SER SER GLY ASN LYS GLU SEQRES 26 B 506 PHE LYS GLY THR VAL PHE PHE ASP GLU PHE THR PHE VAL SEQRES 27 B 506 LYS LEU THR GLY VAL ALA GLY ASN TYR THR VAL CYS GLN SEQRES 28 B 506 LYS ASP LEU CYS CYS HIS LEU SER TYR LYS MET SER GLU SEQRES 29 B 506 ASN ILE PRO ASN GLU VAL TYR ALA LEU GLY ALA PHE ASP SEQRES 30 B 506 GLY LEU HIS THR VAL GLU GLY ARG TYR TYR LEU GLN ILE SEQRES 31 B 506 CYS THR LEU LEU LYS CYS LYS THR THR ASN LEU ASN THR SEQRES 32 B 506 CYS GLY ASP SER ALA GLU THR ALA SER THR ARG PHE GLU SEQRES 33 B 506 MET PHE SER LEU SER GLY THR PHE GLY THR GLN TYR VAL SEQRES 34 B 506 PHE PRO GLU VAL LEU LEU SER GLU ASN GLN LEU ALA PRO SEQRES 35 B 506 GLY GLU PHE GLN VAL SER THR ASP GLY ARG LEU PHE SER SEQRES 36 B 506 LEU LYS PRO THR SER GLY PRO VAL LEU THR VAL THR LEU SEQRES 37 B 506 PHE GLY ARG LEU TYR GLU LYS ASP TRP ALA SER ASN ALA SEQRES 38 B 506 SER SER GLY LEU THR ALA GLN ALA ARG ILE ILE MET LEU SEQRES 39 B 506 ILE VAL ILE ALA PRO ILE VAL CYS SER LEU SER TRP MODRES 4CYF ASN A 38 ASN GLYCOSYLATION SITE MODRES 4CYF ASN A 130 ASN GLYCOSYLATION SITE MODRES 4CYF ASN A 315 ASN GLYCOSYLATION SITE MODRES 4CYF ASN A 353 ASN GLYCOSYLATION SITE MODRES 4CYF ASN B 130 ASN GLYCOSYLATION SITE MODRES 4CYF ASN B 315 ASN GLYCOSYLATION SITE MODRES 4CYF ASN B 353 ASN GLYCOSYLATION SITE MODRES 4CYF CSO A 211 CYS S-HYDROXYCYSTEINE MODRES 4CYF CSO B 211 CYS S-HYDROXYCYSTEINE HET CSO A 211 7 HET CSO B 211 7 HET NAG C 1 14 HET NAG C 2 14 HET NAG A 601 14 HET NAG A 602 14 HET NAG A 603 14 HET NAG B 601 14 HET NAG B 602 14 HET NAG B 603 14 HETNAM CSO S-HYDROXYCYSTEINE HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE FORMUL 1 CSO 2(C3 H7 N O3 S) FORMUL 3 NAG 8(C8 H15 N O6) FORMUL 10 HOH *240(H2 O) HELIX 1 AA1 SER A 45 ASP A 69 1 25 HELIX 2 AA2 ASN A 88 TYR A 93 1 6 HELIX 3 AA3 PRO A 94 LEU A 96 5 3 HELIX 4 AA4 ASP A 101 ASN A 105 5 5 HELIX 5 AA5 THR A 118 ASN A 131 1 14 HELIX 6 AA6 THR A 210 PHE A 216 5 7 HELIX 7 AA7 PRO A 219 ASP A 226 1 8 HELIX 8 AA8 SER A 246 ARG A 259 1 14 HELIX 9 AA9 TYR A 269 LYS A 273 5 5 HELIX 10 AB1 THR A 317 SER A 322 1 6 HELIX 11 AB2 ASN A 407 CYS A 411 5 5 HELIX 12 AB3 GLU A 444 GLN A 446 5 3 HELIX 13 AB4 TYR A 480 ASP A 483 5 4 HELIX 14 AB5 SER B 45 GLN B 70 1 26 HELIX 15 AB6 ASN B 88 TYR B 93 1 6 HELIX 16 AB7 PRO B 94 LEU B 96 5 3 HELIX 17 AB8 ASP B 101 ASN B 105 5 5 HELIX 18 AB9 THR B 118 ASN B 131 1 14 HELIX 19 AC1 THR B 210 PHE B 216 5 7 HELIX 20 AC2 PRO B 219 ASP B 226 1 8 HELIX 21 AC3 SER B 246 ARG B 259 1 14 HELIX 22 AC4 TYR B 269 LYS B 273 5 5 HELIX 23 AC5 THR B 317 SER B 322 1 6 HELIX 24 AC6 ASN B 407 CYS B 411 5 5 HELIX 25 AC7 GLU B 444 GLN B 446 5 3 HELIX 26 AC8 TYR B 480 ASP B 483 5 4 SHEET 1 AA1 6 LEU A 172 HIS A 177 0 SHEET 2 AA1 6 ARG A 157 PHE A 166 -1 N ASP A 163 O TYR A 176 SHEET 3 AA1 6 TYR A 134 PRO A 144 -1 N ILE A 139 O THR A 162 SHEET 4 AA1 6 ILE A 74 VAL A 76 1 N ILE A 75 O VAL A 136 SHEET 5 AA1 6 THR A 24 GLU A 31 1 N TYR A 30 O VAL A 76 SHEET 6 AA1 6 LYS A 298 ASP A 305 -1 O LYS A 298 N GLU A 31 SHEET 1 AA2 6 THR A 198 THR A 201 0 SHEET 2 AA2 6 GLY A 204 ILE A 208 -1 O PHE A 206 N PHE A 199 SHEET 3 AA2 6 THR A 231 THR A 236 1 O THR A 231 N GLY A 207 SHEET 4 AA2 6 ASN A 261 ASN A 266 1 O LEU A 263 N ILE A 232 SHEET 5 AA2 6 SER A 277 TYR A 280 -1 O TYR A 280 N PHE A 262 SHEET 6 AA2 6 SER A 285 HIS A 289 -1 O ARG A 286 N ILE A 279 SHEET 1 AA3 6 GLU A 332 VAL A 337 0 SHEET 2 AA3 6 ASP A 340 LYS A 346 -1 O PHE A 344 N PHE A 333 SHEET 3 AA3 6 TYR A 378 HIS A 387 -1 O LEU A 380 N VAL A 345 SHEET 4 AA3 6 TYR A 393 LYS A 402 -1 O THR A 399 N GLY A 381 SHEET 5 AA3 6 VAL A 470 ARG A 478 -1 O VAL A 473 N LEU A 400 SHEET 6 AA3 6 VAL A 436 LEU A 442 -1 N GLU A 439 O THR A 474 SHEET 1 AA4 5 ALA A 351 GLN A 358 0 SHEET 2 AA4 5 LEU A 361 MET A 369 -1 O CYS A 363 N VAL A 356 SHEET 3 AA4 5 PHE A 422 GLY A 429 -1 O SER A 428 N HIS A 364 SHEET 4 AA4 5 LEU A 460 SER A 462 -1 O LEU A 460 N LEU A 427 SHEET 5 AA4 5 PHE A 452 VAL A 454 -1 N GLN A 453 O PHE A 461 SHEET 1 AA5 6 LEU B 172 HIS B 177 0 SHEET 2 AA5 6 ARG B 157 PHE B 166 -1 N ASP B 163 O TYR B 176 SHEET 3 AA5 6 TYR B 134 PRO B 144 -1 N ILE B 139 O THR B 162 SHEET 4 AA5 6 ILE B 74 VAL B 76 1 N ILE B 75 O VAL B 136 SHEET 5 AA5 6 THR B 24 GLU B 31 1 N TYR B 30 O VAL B 76 SHEET 6 AA5 6 LYS B 298 ASP B 305 -1 O LYS B 298 N GLU B 31 SHEET 1 AA6 6 THR B 198 THR B 201 0 SHEET 2 AA6 6 GLY B 204 ILE B 208 -1 O PHE B 206 N PHE B 199 SHEET 3 AA6 6 THR B 231 THR B 236 1 O THR B 231 N GLY B 207 SHEET 4 AA6 6 ASN B 261 ASN B 266 1 O LEU B 263 N ILE B 232 SHEET 5 AA6 6 SER B 277 TYR B 280 -1 O TYR B 280 N PHE B 262 SHEET 6 AA6 6 SER B 285 HIS B 289 -1 O ARG B 286 N ILE B 279 SHEET 1 AA7 6 GLU B 332 VAL B 337 0 SHEET 2 AA7 6 ASP B 340 LYS B 346 -1 O PHE B 344 N PHE B 333 SHEET 3 AA7 6 TYR B 378 HIS B 387 -1 O LEU B 380 N VAL B 345 SHEET 4 AA7 6 TYR B 393 LYS B 402 -1 O THR B 399 N GLY B 381 SHEET 5 AA7 6 VAL B 470 ARG B 478 -1 O VAL B 473 N LEU B 400 SHEET 6 AA7 6 VAL B 436 LEU B 442 -1 N GLU B 439 O THR B 474 SHEET 1 AA8 5 ALA B 351 GLN B 358 0 SHEET 2 AA8 5 LEU B 361 MET B 369 -1 O CYS B 363 N VAL B 356 SHEET 3 AA8 5 PHE B 422 GLY B 429 -1 O SER B 428 N HIS B 364 SHEET 4 AA8 5 LEU B 460 SER B 462 -1 O LEU B 460 N LEU B 427 SHEET 5 AA8 5 PHE B 452 VAL B 454 -1 N GLN B 453 O PHE B 461 SSBOND 1 CYS A 109 CYS A 126 1555 1555 2.08 SSBOND 2 CYS A 145 CYS A 152 1555 1555 2.05 SSBOND 3 CYS A 357 CYS A 362 1555 1555 2.07 SSBOND 4 CYS A 363 CYS A 398 1555 1555 2.05 SSBOND 5 CYS A 403 CYS A 411 1555 1555 2.02 SSBOND 6 CYS B 109 CYS B 126 1555 1555 2.06 SSBOND 7 CYS B 145 CYS B 152 1555 1555 2.05 SSBOND 8 CYS B 357 CYS B 362 1555 1555 2.08 SSBOND 9 CYS B 363 CYS B 398 1555 1555 2.06 SSBOND 10 CYS B 403 CYS B 411 1555 1555 2.03 LINK ND2 ASN A 38 C1 NAG A 603 1555 1555 1.45 LINK ND2 ASN A 130 C1 NAG A 601 1555 1555 1.43 LINK C THR A 210 N CSO A 211 1555 1555 1.33 LINK C CSO A 211 N PHE A 212 1555 1555 1.33 LINK ND2 ASN A 315 C1 NAG A 602 1555 1555 1.45 LINK ND2 ASN A 353 C1 NAG C 1 1555 1555 1.44 LINK ND2 ASN B 130 C1 NAG B 603 1555 1555 1.45 LINK C THR B 210 N CSO B 211 1555 1555 1.33 LINK C CSO B 211 N PHE B 212 1555 1555 1.33 LINK ND2 ASN B 315 C1 NAG B 601 1555 1555 1.46 LINK ND2 ASN B 353 C1 NAG B 602 1555 1555 1.45 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.45 CISPEP 1 ASP A 218 PRO A 219 0 2.82 CISPEP 2 LEU A 242 PRO A 243 0 5.23 CISPEP 3 ASP B 218 PRO B 219 0 -0.25 CISPEP 4 LEU B 242 PRO B 243 0 4.92 CRYST1 119.941 119.941 221.887 90.00 90.00 90.00 P 43 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008337 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008337 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004507 0.00000